Table 1.
Baseline characteristics of patients with stages 3–4 CKD, stratified by Hb and HbA1c quartiles.
Table 2.
Clinical outcomes of patients with stages 3–4 CKD, stratified by Hb and HbA1c quartiles.
Table 3.
Multivariable linear regression of HbA1c levels.
Fig 1.
Regression diagram for HbA1c and Hb levels among subjects with (A) Hb < 10 g/dL and (B) Hb ≥ 10 g/dL.
Table 4.
Risk of outcomes among subjects with Hb < 10 g/dL and Hb ≥ 10 g/dL, stratified by HbA1c quartiles.